
Cloud-based Intelligent Clinical Operating System Provider

Developer, Manufacturer, and Seller of Medical Monitoring Instruments
On January 17, 2020, VCBeat (WeChat ID: vcbeat) learned via Business Wire that Masimo, the global leader in non-invasive monitoring technology, announced the signing of a definitive agreement to acquire NantHealth’s internet care business, Connected Care, for $47.25 million. The transaction is expected to be completed in the first quarter of 2020.
It is reported that this acquisition aligns with Masimo’s strategic development goals, which aim to help hospitals improve the standard of care through automation, connectivity, and innovative non-invasive monitoring technologies. Connected Care is a recognized leader in care solutions, simplifying the collection and storage of medical device data via third-party platforms and integrating it into electronic health records (EHR) or other clinical information systems.
NantHealth, founded in 2007 and headquartered in California, USA, is a provider of cloud-based intelligent clinical operating systems. The company’s core product is CLINICS, a comprehensive intelligent learning clinical system designed to collect and analyze vast amounts of clinical data, thereby further optimizing the system’s clinical pathways and decision-making algorithms. By leveraging the CLINICS system, pharmaceutical companies can accelerate new drug development, while patients can stay informed about their health status in a timely manner. NantHealth went public on the NASDAQ Stock Exchange in June 2016 under the ticker symbol NH.
NantHealth integrates scientific technology with advanced equipment through an integrated clinical platform to help doctors, patients, and researchers overcome barriers in traditional healthcare. The company’s team improves diagnostic processes to better identify and diagnose diseases, transforms clinical delivery through clinical data, and safeguards patient health. NantHealth states that it is building a comprehensive, personalized care solution based on clinical data and genomic information to promote the transformation and development of the healthcare industry.
Masimo (NASDAQ: MASI), founded in 1989 and headquartered in California, USA, is a global medical technology company. The company is dedicated to developing and manufacturing leading monitoring technologies and devices for the healthcare industry, including measurement instruments, sensors, pulse oximeters, patient monitors, and automation equipment. Masimo’s mission is to improve patient outcomes and reduce care costs.
Joe Kiani, Founder, Chairman, and CEO of Masimo, stated, “One of Masimo’s strategic priorities is to alleviate the burden on clinicians through automated solutions and to enhance care delivery through connectivity, predictive algorithms, and decision support. NantHealth’s care business will help us expand our customer base and achieve our organic growth objectives. We warmly welcome the Connected Care team to Masimo and look forward to realizing our shared vision.”
Dr. Patrick Soon-Shiong, CEO and Chairman of the Board of NantHealth, stated, “Our decision to sell Connected Care is aimed at focusing on the development of data and molecular analytics systems, providing NaviNet and Eviti SaaS solutions to healthcare institutions and enterprises. We are pleased to have found a suitable new home for the Connected Care team.”
(Compiled by Xu Xiaoxue)